Literature DB >> 389269

Corticosteroids, aurothioglucose and soybean trypsin inhibitor do not prevent pemphigus antibody-induced acantholysis in vitro.

J R Schiltz, C H Hu, B Michel.   

Abstract

Hydrocortisone, triamcinolone acetonide, aurothioglucose and soybean trypsin inhibitor were added to normal human skin explants cultured with IgG from pemphigus serum to determine if acantholysis could be prevented. At the therapeutic concentrations used none of these compounds prevented binding of the autoantibody to the epidermal target cells, and none prevented acantholysis. These experiments support the concepts that the pemphigus antibody alone is responsible for producing the acantholytic lesions of pemphigus, that the therapeutic effectiveness of steroids and gold salts is probably due to their ability to reduce serum autoantibody titres and that pemphigus acantholysis is probably not caused by a serine proteinase.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 389269     DOI: 10.1111/j.1365-2133.1979.tb05620.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  4 in total

1.  Role of plasminogen activator in pemphigus vulgaris.

Authors:  J E Wilkinson; C A Smith; M M Suter; W Falchek; R M Lewis
Journal:  Am J Pathol       Date:  1989-03       Impact factor: 4.307

Review 2.  Antibody-induced proteinase activation: a proposed mechanism for pemphigus.

Authors:  K H Singer; K Hashimoto; G S Lazarus
Journal:  Springer Semin Immunopathol       Date:  1981-06

3.  Platelet-derived factors enhance pemphigus acantholysis in skin organ cultures.

Authors:  T Hunziker; U E Nydegger; P G Lerch; J D Vassalli
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

4.  High doses of antigen-nonspecific IgG do not inhibit pemphigus acantholysis in skin organ cultures.

Authors:  T Hunziker; U E Nydegger; P J Späth; H A Gerber; M Hess; U Wiesmann; A Krebs
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.